Bill: Do you support "Improving Access to Affordable Prescription Drugs" (HR 1776) (Schakowsky)?

Yes. It protects the public interest to allow the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies to drive down costs by leveraging its purchasing power. The bill’s other components, such as requiring GAO reports to Congress on such CMS negotiations, are poised to help ensure its effectiveness.

Read the full bill on ›